Clinical Trials Browser

Phase 2 × Melanoma × Vorinostat × Clear all

NCT00121225 2019-01-29

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

Phase 2 Completed

32 enrolled 11 charts

Uveal Melanoma, Melanoma